期刊文献+

尼群地平与美托洛尔联用治疗老年性高血压病92例疗效观察 被引量:2

The curative effect of combined application of nitrendipine with metoprolol on the 92 elder patients with hypertension
暂未订购
导出
摘要 目的:探讨尼群地平联合美托洛尔治疗1-2级高血压的临床疗效。方法:将92例患者随机分为3组:A组31例,给予尼群地平片10 mg,2-3次/d;B组31例,给予美托洛尔25-50 mg,2次/d。C组30例,给予尼群地平10 mg,2-3次/d同时加服美托洛尔12.5-25 mg,2次/d。然后每周依据血压调整1次药物剂量,尽量使血压控制在140/90 mmHg以下,疗程均为6周。结果:C组的降压效果、心率减慢以及收缩压、舒张压平均下降幅度均显著大于A,B组(P〈0.05),不良反应的发生率较A,B组低(P〈0.05)。结论:尼群地平联合美托洛尔降压作用肯定;两药联合使用安全且价格低廉。 Objective: To evaluate of clinical effect of the combined use of Nitrendipine with Metoprolol in treating patients with level I and II hypertension.Methods: 92 patients with level I and II hypertension were randomly divided into 3 groups: group A(31 patients) took 10mg of Nitrendipine,2~3 times a day;group B(31 patients) received the treatment of 25 mg-50 mg of Metoprolol,2 times a day;while group C(30 patients) received the treatment of taking 10 mg of Nitrendipine and 12.5 mg - 25 mg of Metoprolol 2 times a day.Then,the dose of drug was adjusted based on the level of the blood pressure,which was controled under the level of 140/90 mmHg(1 mmHg = 0.133 ksPa) to the greatest extent.The course of treatment is 6 weeks without exception.Results: The effect of lowering blood pressure,the slow down of the heart rate and the decreased systolic pressure and diastolic pressure in Group C were greater than those in Group A and Group B(P〈0.05);the incidence of drug adverse reactions was lower than that of Group A and Group B(P〈0.05).Conclusion: The Decompression effect of Nitrendipine and Metoprolol has been confirmed.Besides,they are safe in use and economical.
出处 《华夏医学》 CAS 2010年第5期491-493,共3页 Acta Medicinae Sinica
关键词 高血压 尼群地平 美托洛尔 联合应用 hypertension nitrendipine metoprolol combined application
  • 相关文献

参考文献4

二级参考文献12

  • 1王文,成云芳,刘力生.中国北京上海广州门诊高血压患者脑卒中风险评估[J].中华高血压杂志,2007,15(z1):14-20. 被引量:16
  • 2[2]Dahlof B,Sever PS,Poulter NR,et al.Prevention of cardiovascu-lar events with an antihypertensive regimen of amlodipine adding peridopril as required versus atenolol adding benddroflumethiazide as required in the Anglo-acandinavian cardiac outcomes trial-blood pressure lowering arm (ASCOT-BPLA):a multicentre randomized controlled trial[J].Lancet,2005,366:895-906.
  • 3[3]Wang JG,Li Y,Franklin SS,et al.Prevention of stroke and my-ocardial infarction by amlodipine and angiotesin receptor blockers:a quantitative overview[J].Hypertension,2007,50:181-188.
  • 4[6]Jamerson KA,ACCOMPLISH group.The first hypertension trial comparing the effects of two fixed-dose combination therapy regi-mens on cardiovascular events:Avoiding cardiovascular events through combination therapy in patients living with systolic hyper-tension (ACCOMPLISH)[J].J Clin H ypertens,2003,5 (Suppl 3) 29-35.
  • 5[8]Haller H.Effective management of hypertension with dihydropyr-idine calcium channer blocker based combination therapy in pa-tients at high cardiovascular risk[J].Int J Clin Pract,2008,62:781-790.
  • 6Epstei M ,Bakris G. Newer approaches to antihypertensire therapy. Use of fixeddose combination therapy. Arch Intern Med,1996,156 (17):1969-1978.
  • 7Shoji T ,Aki Y ,Horiuchi K ,et al. Regional hemodynamic effects of betaxolol, a new Selective beta 1-blocker, and atenolol in. Conseions spontaneously hypertensive rats.Jpn J pharmacol,1992,60(3):253-259.
  • 8Wilbert S, Aronow MD ,Chul Ahn phD ,et al. Association of average heart rate on 24-hour ambulatory electrocardiograms. With Incidence of new coronary events at . 48-month follow-up in 1311 patients (Mean Age 81 years) with heart disease sinus rhythm. Am J Cardiol, 1996,78(10):1175-1176.
  • 9Edward D,Frohlich MD. Current clinical pathophysiologic considerations in essntial hyperter sion. Med Clini N Am,1997,81(5):1 113-1 129.
  • 10王文,马丽媛,张宇清,邓卿,刘明波,刘力生,代表CHIEF研究协作组.中国高血压综合干预研究方案——起始联合降压、适度调脂和生活方式综合干预的全国多中心随机对照试验[J].中国循证医学杂志,2007,7(11):810-815. 被引量:31

共引文献81

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部